CAS: 16506-27-7 - Bendamustine
Formula:C16H21Cl2N3O2
InChI:InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)
InChI key:InChIKey=YTKUWDBFDASYHO-UHFFFAOYSA-N
SMILES:O=C(O)CCCC1=NC=2C=C(C=CC2N1C)N(CCCl)CCCl
- Synonyms:
- 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
- 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
- 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
- ω-[1-Methyl-5-[bis(β-chloroethyl)amino]-2-benzimidazolyl]butyric acid
- Bendamustine
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid
CAS:16506-27-7
Formula:
C16H21Cl2N3O2
Purity:
%
Color and Shape:
Solid
Molecular weight:
358.2628
Ref: IN-DA007VAS
25mg | 188.00 € | ||
50mg | 182.00 € | ||
100mg | 290.00 € | ||
250mg | 643.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Bendamustine
CAS:16506-27-7
Bendamustine (SDX105) for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
Formula:
C16H21Cl2N3O2
Purity:
97.38% - ≥98%
Color and Shape:
Solid
Molecular weight:
358.26
Ref: TM-T8380
1mg | 38.00 € | ||
2mg | 49.00 € | ||
5mg | 78.00 € | ||
10mg | 118.00 € | ||
25mg | 255.00 € | ||
50mg | 398.00 € | ||
100mg | 594.00 € | ||
500mg | 1,280.00 € | ||
1mL*10mM (DMSO) | 94.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid
CAS:16506-27-7
Purity:
95.0%
Molecular weight:
358.260009765625
Ref: 10-F436912
1g | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Bendamustine
Controlled ProductCAS:16506-27-7
Applications Bendamustine is an intermediate in the synthesis of Bendamustine 3-Hydroxyprop-2-yl Ester (B132550), which is …
Formula:
C16H21Cl2N3O2
Color and Shape:
Neat
Molecular weight:
358.263
Ref: TR-B132558
250mg | 1,060.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
CAS:16506-27-7
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid (BCBA) is an experimental cancer drug that is being investigated for the treatment …
Formula:
C16H21Cl2N3O2
Purity:
Min. 95%
Molecular weight:
358.26 g/mol
Ref: 3D-FB32117
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025